- Home
- ARQT vs JBLU Comparison
ARQT vs JBLU Comparison
Compare ARQT & JBLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- JBLU
- Stock Information
- Founded
- ARQT 2016
- JBLU 1998
- Country
- ARQT United States
- JBLU United States
- Employees
- ARQT N/A
- JBLU N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- JBLU Air Freight/Delivery Services
- Sector
- ARQT Health Care
- JBLU Consumer Discretionary
- Exchange
- ARQT Nasdaq
- JBLU Nasdaq
- Market Cap
- ARQT 1.7B
- JBLU 1.5B
- IPO Year
- ARQT 2020
- JBLU N/A
- Fundamental
- Price
- ARQT $15.00
- JBLU $4.39
- Analyst Decision
- ARQT Strong Buy
- JBLU Sell
- Analyst Count
- ARQT 6
- JBLU 11
- Target Price
- ARQT $18.80
- JBLU $4.97
- AVG Volume (30 Days)
- ARQT 2.0M
- JBLU 19.3M
- Earning Date
- ARQT 08-13-2025
- JBLU 07-29-2025
- Dividend Yield
- ARQT N/A
- JBLU N/A
- EPS Growth
- ARQT N/A
- JBLU N/A
- EPS
- ARQT N/A
- JBLU N/A
- Revenue
- ARQT $212,819,000.00
- JBLU $9,210,000,000.00
- Revenue This Year
- ARQT $61.15
- JBLU N/A
- Revenue Next Year
- ARQT $37.98
- JBLU $7.75
- P/E Ratio
- ARQT N/A
- JBLU N/A
- Revenue Growth
- ARQT 100.03
- JBLU N/A
- 52 Week Low
- ARQT $7.86
- JBLU $3.34
- 52 Week High
- ARQT $17.75
- JBLU $8.31
- Technical
- Relative Strength Index (RSI)
- ARQT 60.23
- JBLU 47.73
- Support Level
- ARQT $13.06
- JBLU $4.18
- Resistance Level
- ARQT $15.36
- JBLU $4.81
- Average True Range (ATR)
- ARQT 0.66
- JBLU 0.23
- MACD
- ARQT 0.12
- JBLU 0.03
- Stochastic Oscillator
- ARQT 82.57
- JBLU 56.70
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About JBLU JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.